Recent US retreat in mRNA vaccines and therapies could open the door for Europe in its upcoming #BiotechAct.

The European Parliament's Environment, Climate and Food Safety Committee (ENVI) has delivered the first parliamentary opinion on the European Commission's proposed Biotech Act

The European Commission launches today two initiatives under its Preparedness Union agenda: an EU Stockpiling Strategy and a Medical Countermeasures Strategy. Both are designed to improve access to es...

Why is the Commission proposing a Biotech Act?\nBiotechnology is essential to the EU\'s competitiveness, strategic autonomy and economic security. It is one of the fastest growing innovative industrie...

European Commission - Have your say

(Adnkronos) - "L'intero potenziale delle biotecnologie europee non viene ancora pienamente valorizzato: le imprese si trovano a dover affrontare ostacoli burocratici, complessità normative e difficoltà nel portare innovazione sul merc...

(Adnkronos) - In occasione della sua Assemblea annuale, Assobiotec-Federchimica organizza il convegno pubblico: “Biotech Act: opportunità e sfide per l’Italia e per l’Europa nel nuovo scenario geopolitico” per domani, Mercoled?...

🔬Today, on International #ClinicalTrialsDay, I want to thank all those who make clinical research possible across Europe To universities, hospitals, doctors, nurses, pharmacists, study teams, public research institutes, pharmaceutical and biotech companies - and above all, to the patients and participants who place their trust in research - thank you 👏 Clinical trials turn science into evidence, and evidence into better care. Every year, around 2,900 clinical trial applications are submitted in the European Union. They can give patients early access to some of the most innovative therapies - sometimes years before they reach the market. But Europe is facing strong global competition. We cannot afford to lose ground. That is why we are acting through the #BiotechAct, the revision of the Clinical Trials Regulation and through FAST EU - to build a more agile, innovation-friendly system, accelerate procedures, make better use of data and AI, and make it easier to run multi-country trials across Europe. 🧪 Europe has the science. 💡 Europe has the talent. ✅ Europe has high standards. Let us keep building a Europe where research is trusted, innovation is welcomed, and patients are at the heart of every breakthrough. 🎥 Watch and share my message below #InternationalClinicalTrialsDay #ClinicalTrials #BiotechAct #EUHealth #Innovation #Research #Patients European Medicines Agency European Commission EU Health and Food Safety European Patients'​ Forum European University Hospital Alliance (EUHA) ECRIN (European Clinical Research Infrastructure Network) EFPIA - European Federation of Pharmaceutical Industries and Associations